OKUR OnKure Therapeutics reports narrower Q4 2025 loss than estimates shares drop 204 percent in trading Brightstar BRSL Stock Movement Analysis Q4 2025 Earnings Beat Estimates UNCY Unicycive Therapeutics reports wide Q4 2025 EPS miss shares dip slightly amid soft investor sentiment